Cadrenal Therapeutics, Inc. Annual Depreciation in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2022 to 2023.
  • Cadrenal Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $407.000, a 31.8% decline year-over-year.
  • Cadrenal Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.07K.
  • Cadrenal Therapeutics, Inc. annual Depreciation for 2023 was $1.98K, a 56.4% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.98K +$714 +56.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $1.27K Jan 25, 2022 Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.